Chan, K. H., Sridhar, S., Zhang, R. R., Chu, H., Fung, A. Y. F., Chan, G., Chan, J. F. W., To, K. K. W., Hung, I. F. N., Cheng, V. C. C., & Yuen, K. Y. (2020). Factors affecting stability and infectivity of SARS-CoV-2. Journal of Hospital Infection, 106, 226–231.

Article  PubMed  Google Scholar 

Harrison, A. G., Lin, T., & Wang, P. (2020). Mechanisms of SARS-CoV-2 transmission and pathogenesis. Trends in Immunology, 41, 1100–1115.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Burki, T. (2023). First shared SARS-CoV-2 genome: GISAID vs virological.org. The Lancet Microbe., 4, 395.

Article  Google Scholar 

Rastogi, M., Pandey, N., Shukla, A., & Singh, S. K. (2020). SARS coronavirus 2: From genome to infectome. Respiratory Research, 21, 318.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ashraf, M., Sharif, S., Ahmad, M., Zahid, M., & Mukhtar, H. (2021). A review on clinical, pathological characteristics and drug designing for COVID-19. Arab J Basic Appl Sci., 28, 172–186.

Google Scholar 

Puranik, A., Lenehan, P. J., Silvert, E., Niesen, M. J. M., Corchado-Garcia, J., O’Horo, J. C., Virk, A., Swift, M. D., Halamka, J., Badley, A. D., Venkatakrishnan, A. J. and Soundararajan, V. (2021) medRxiv : the preprint server for health sciences.

Voysey, M., Clemens, S. A. C., Madhi, S. A., Weckx, L. Y., Folegatti, P. M., Aley, P. K., Angus, B., Baillie, V. L., Barnabas, S. L., Bhorat, Q. E., Bibi, S., Briner, C., Cicconi, P., Collins, A. M., Colin-Jones, R., Cutland, C. L., Darton, T. C., Dheda, K., Duncan, … Zuidewind, P. (2021) Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: An interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. The Lancet. 397, 99–111.

Zhang, Y., Belayachi, J., Yang, Y., Fu, Q., Rodewald, L., Li, H., Yan, B., Wang, Y., Shen, Y., Yang, Q., Mu, W., Tang, R., Su, C., Xu, T., Obtel, M., Mhayi, A., Razine, R., Abouqal, R., Zhang, Y., & Yang, X. (2022). Real-world study of the effectiveness of BBIBP-CorV (Sinopharm) COVID-19 vaccine in the Kingdom of Morocco. BMC Public Health, 22, 1584.

Article  PubMed  PubMed Central  Google Scholar 

Duffy, S. (2018). Why are RNA virus mutation rates so damn high? PLoS Biology, 16, e3000003.

Article  PubMed  PubMed Central  Google Scholar 

Sanyaolu, A., Okorie, C., Marinkovic, A., Haider, N., Abbasi, A. F., Jaferi, U., Prakash, S., & Balendra, V. (2021). The emerging SARS-CoV-2 variants of concern. Ther Adv Infect Dis., 8, 20499361211024372.

CAS  PubMed  PubMed Central  Google Scholar 

Thye, A.Y.-K., Law, J.W.-F., Pusparajah, P., Letchumanan, V., Chan, K.-G., & Lee, L.-H. (2021). Psychological symptoms in COVID-19 patients: Insights into pathophysiology and risk factors of long COVID-19. Biology., 9, 1303.

CAS  Google Scholar 

Samrat, S. K., Tharappel, A. M., Li, Z., & Li, H. (2020). Prospect of SARS-CoV-2 spike protein: Potential role in vaccine and therapeutic development. Virus Research, 288, 198141.

Article  CAS  PubMed  Google Scholar 

Collier, D. A., De Marco, A., Ferreira, I. A., Meng, B., Datir, R. P., Walls, A. C., Kemp, S. A., Bassi, J., Pinto, D., & Silacci-Fregni, C. (2021). Sensitivity of SARS-CoV-2 B. 1.1. 7 to mRNA vaccine-elicited antibodies. Nature, 593, 136–141.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Madhi, S. A., Baillie, V., Cutland, C. L., Voysey, M., Koen, A. L., Fairlie, L., Padayachee, S. D., Dheda, K., Barnabas, S. L., & Bhorat, Q. E. (2021). Efficacy of the ChAdOx1 nCoV-19 Covid-19 vaccine against the B.1.351 variant. NEJM, 384, 1885–1898.

Article  CAS  PubMed  Google Scholar 

Wu, K., Werner, A. P., Moliva, J. I., Koch, M., Choi, A., Stewart-Jones, G. B., Bennett, H., Boyoglu-Barnum, S., Shi, W. and Graham, B. S. (2021) bioRxiv : the preprint server for biology, 2021.2001. 2025.427948.

Cele, S., Jackson, L., Khoury, D. S., Khan, K., Moyo-Gwete, T., Tegally, H., San, J. E., Cromer, D., Scheepers, C., & Amoako, D. G. (2022). Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization. Nature, 602, 654–656.

Article  CAS  PubMed  Google Scholar 

Cheng, S. M., Mok, C. K. P., Leung, Y. W., Ng, S. S., Chan, K. C., Ko, F. W., Chen, C., Yiu, K., Lam, B. H., & Lau, E. H. (2022). Neutralizing antibodies against the SARS-CoV-2 Omicron variant BA. 1 following homologous and heterologous CoronaVac or BNT162b2 vaccination. Nature Medicine, 28, 486–489.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Noh, J. Y., Jeong, H. W., & Shin, E.-C. (2021). SARS-CoV-2 mutations, vaccines, and immunity: Implication of variants of concern. Signal Transduction and Targeted Therapy, 6, 203.

Article  CAS  PubMed  PubMed Central  Google Scholar 

WHO (2024) WHO COVID-19 dashboard.

Otto, S. P., Day, T., Arino, J., Colijn, C., Dushoff, J., Li, M., Mechai, S., Van Domselaar, G., Wu, J., & Earn, D. J. (2021). The origins and potential future of SARS-CoV-2 variants of concern in the evolving COVID-19 pandemic. Current Biology, 31, R918–R929.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chalkias, S., Whatley, J., Eder, F., Essink, B., Khetan, S., Bradley, P., Brosz, A., McGhee, N., Tomassini, J. E. and Chen, X. (2022) medRxiv : the preprint server for health sciences.

Chaudhary, J. K., Yadav, R., Chaudhary, P. K., Maurya, A., Kant, N., Rugaie, O. A., Haokip, H. R., Yadav, D., Roshan, R., & Prasad, R. (2021). Insights into COVID-19 vaccine development based on immunogenic structural proteins of SARS-CoV-2, host immune responses, and herd immunity. Cells, 10, 2949.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen, H.-Z., Tang, L.-L., Yu, X.-L., Zhou, J., Chang, Y.-F., & Wu, X. (2020). Bioinformatics analysis of epitope-based vaccine design against the novel SARS-CoV-2. Infectious Diseases of Poverty, 9, 88.

Article  PubMed  PubMed Central  Google Scholar 

Mei, S., Li, F., Leier, A., Marquez-Lago, T. T., Giam, K., Croft, N. P., Akutsu, T., Smith, A. I., Li, J., & Rossjohn, J. (2020). A comprehensive review and performance evaluation of bioinformatics tools for HLA class I peptide-binding prediction. Briefings in Bioinformatics, 21, 1119–1135.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hellerstein, M. (2020). What are the roles of antibodies versus a durable, high quality T-cell response in protective immunity against SARS-CoV-2? Vaccine., 6, 100076.

CAS  Google Scholar 

Kogay, R., & Schönbach, C. (2019). Epitope predictions. In S. Ranganathan, M. Gribskov, K. Nakai, & C. Schönbach (Eds.), Encyclopedia of bioinformatics and computational biology (pp. 952–971). Academic Press.

Chapter  Google Scholar 

Sanchez-Trincado, J. L., Gomez-Perosanz, M., & Reche, P. A. (2017). Fundamentals and methods for T- and B-cell epitope prediction. Journal of Immunology Research, 2017, 2680160.

Article  PubMed  PubMed Central  Google Scholar 

Lapuente, D., Winkler, T. H., & Tenbusch, M. (2024). B-cell and antibody responses to SARS-CoV-2: Infection, vaccination, and hybrid immunity. Cellular & Molecular Immunology, 21, 144–158.

Article  CAS  Google Scholar 

Sidney, J., Peters, B., & Sette, A. (2020). Epitope prediction and identification- adaptive T cell responses in humans. Seminars in Immunology, 50, 101418.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Choy, C., Chen, J., Li, J., Gallagher, D. T., Lu, J., Wu, D., Zou, A., Hemani, H., Baptiste, B. A., Wichmann, E., Yang, Q., Ciffelo, J., Yin, R., McKelvy, J., Melvin, D., Wallace, T., Dunn, C., Nguyen, C., Chia, C. W., … Weng, N. P. (2023). SARS-CoV-2 infection establishes a stable and age-independent CD8+ T cell response against a dominant nucleocapsid epitope using restricted T cell receptors. Nature Communications, 14, 6725.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Khatri, I., Staal, F. J. T., & van Dongen, J. J. M. (2020). Blocking of the high-affinity interaction-synapse between SARS-CoV-2 Spike and human ACE2 proteins likely requires multiple high-affinity antibodies: An immune perspective. Frontiers in Immunology, 11, 570018.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gershoni, J. M., Roitburd-Berman, A., Siman-Tov, D. D., Freund, N. T., & Weiss, Y. (2007). Epitope Mapping epitopes. BioDrugs, 21, 145–156.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ayariga, J. A., Gildea, L., Ipimoroti, A. and Matthews, Q. L. (2021) Gp120 alters its conformation to enhance evasiveness and infectivity. SSRN.

Maoz-Segal, R. and Andrade, P. (2015) Molecular Mimicry and Autoimmunity, in Infection and Autoimmunity, pp. 27–44.

Huber, V. C., Lynch, J. M., Bucher, D. J., Le, J., & Metzger, D. W. (2001). Fc receptor-mediated phagocytosis makes a significant contribution to clearance of influenza virus infections. The Journal of Immunology, 166, 7381–7388.

Article  CAS  PubMed  Google Scholar 

Khalid, K., & Poh, C. L. (2023). The promising potential of reverse vaccinology-based next-generation vaccine development over conventional vaccines against antibiotic-resistant bacteria. Vaccines., 11, 1264.